BLOOD GROUPING SERU

Defense Logistics Agency award SPE2DS26P2303 is a firm fixed price contract issued on June 26, 2026, to SZY Holdings, LLC for the procurement of Blood Grouping Serum, Anti-A, Monoclonal. The total contract value is $2,990.00, covering two packages of 10 mL serum units under NSN 6550-01-317-0288. The award is set aside for small businesses and requires delivery by August 10, 2026, to the European Medical Materiel Center in Kaiserslautern, Germany. The contract mandates strict adherence to medical storage and quality standards, requiring the product to be refrigerated between 2C and 8C throughout the supply chain. Items must be delivered with at least 13 months of their 15-month shelf life remaining. Packaging and marking must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, including the use of temperature control labels. Inspection and acceptance will occur at the destination. Administrative requirements include mandatory invoicing through Wide Area WorkFlow (WAWF) and compliance with critical regulatory clauses, including DFARS 252.204-7012 for safeguarding covered defense information and FAR 52.222-50 regarding combating trafficking in persons. The contractor is responsible for all transportation costs and risks under FOB Destination terms.